741 filings
Page 12 of 38
8-K
KA
Kineta, Inc.
12 Sep 22
Kineta Announces Participation in the H.C. Wainwright 24th Annual Global Healthcare Conference
4:00pm
425
KA
Kineta, Inc.
29 Aug 22
Business combination disclosure
4:03pm
8-K
KA
Kineta, Inc.
29 Aug 22
Yumanity Therapeutics Announces Filing of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta
4:01pm
S-4
KA
Kineta, Inc.
Registration of securities issued in business combination transactions
29 Aug 22
12:00am
10-Q
2022 Q2
KA
Kineta, Inc.
Quarterly report
4 Aug 22
5:12pm
8-K
KA
Kineta, Inc.
4 Aug 22
Yumanity Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Developments
4:51pm
425
KA
Kineta, Inc.
20 Jul 22
Business combination disclosure
6:09am
8-K
KA
Kineta, Inc.
20 Jul 22
Regulation FD Disclosure
6:07am
4
Peters Richard
6 Jul 22
YUMANITY THERAPEUTICS / Richard Peters ownership change
4:54pm
425
KA
Kineta, Inc.
28 Jun 22
Business combination disclosure
4:03pm
8-K
KA
Kineta, Inc.
28 Jun 22
Kineta Announces Appointment of Thierry Guillaudeux, PhD to Chief Scientific Officer
4:02pm
425
KA
Kineta, Inc.
17 Jun 22
Business combination disclosure
4:03pm
8-K
KA
Kineta, Inc.
17 Jun 22
Kineta Presents New Preclinical Data and Phase 1/2 Clinical Trial Design of KVA12.1 at the Tumor Myeloid-Directed Therapies Summit
4:02pm
8-K
KA
Kineta, Inc.
9 Jun 22
Submission of Matters to a Vote of Security Holders
4:06pm
4
Marie Epstein
6 Jun 22
YUMANITY THERAPEUTICS / Marie Epstein ownership change
9:49pm
4
Devin Whittemore Smith
6 Jun 22
YUMANITY THERAPEUTICS / Devin Whittemore Smith ownership change
9:46pm
4
Michael D Wyzga
6 Jun 22
YUMANITY THERAPEUTICS / Michael D Wyzga ownership change
9:45pm
4
Peters Richard
6 Jun 22
YUMANITY THERAPEUTICS / Richard Peters ownership change
9:45pm
425
KA
Kineta, Inc.
6 Jun 22
Business combination disclosure
4:05pm
8-K
KA
Kineta, Inc.
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm